NSW Curing Hepatitis C in Primary Care

Treatment with direct acting antivirals is easier than ever. This course aims to provide general practitioners, nurse practitioners and other prescribing practitioners the skills and confidence to diagnose, assess, manage, and treat hepatitis C in primary care. Increasing HCV treatment in primary care is crucial to achieving HCV elimination in Australia by 2030.   

This training uses a blended learning approach and aims to provide participants with the knowledge and confidence to increase screening and management of hepatitis C (HCV) in primary care settings.   

Learning methods include online learning modules, presentations and facilitated case discussions delivered by specialists and GPs with expertise in HCV management and treatment. Interactive sessions provide opportunity for participants to discuss practical strategies with peers and specialists. 

Course Date & Time

Date: Saturday 25 November 2023

Time: 10:00am – 1:00pm (AEDT)

Location: Zoom

Course Components

1. Completion of the pre-course survey
2. Completion of the pre-course Online Learning Module
3. Attendance at the 3-hour interactive webinar
4. Completion of the post-course activity (2 case studies)

Learning Outcomes

By the end of this training program, participants will be able to:    

1. Screen, implement and interpret tests appropriately to diagnose chronic HCV.
2. Explain pre-treatment assessment of HCV patients, including assessment of liver fibrosis.
3. Summarise the goals for HCV therapy and be able to choose the appropriate antiviral therapy for your patient.
4. Identify appropriate management strategies in special populations.
5. Outline appropriate treatment monitoring and post-treatment follow-up including long term care of liver disease after HCV cure. 
6. Discuss strategies to minimise transmission risk and improve liver health.

Presenters/Facilitators

Presenters and facilitators include Dr Thao Lam, Gastroenterologist and Addiction Medicine Specialist, Westmead Hospital. 

Target Audience

General practitioners, nurse practitioners, other practitioners prescribing or intending to prescribe s85 direct-acting antiviral medication for HCV in primary care settings.  

RACGP Accreditation

This activity has been approved for the following hours and types:

Educational Activities (EA): 4.0 hours

Reviewing Performance (RP): 1.5 hours 

Funders

This course is funded by NSW Health.

Further Information:

Please click here to access the flyer.

Please contact ASHM Education, click here to send an email. Or call 0431 320 429 for further assistance.

Help us keep ASHM courses free!

At ASHM, we are committed to developing a sustainable HIV, viral hepatitis, and sexual health workforce. We pride ourselves on the ability to offer high quality educational opportunities, that are free to attend. If you are unable to attend one of our courses, please let us know as soon as possible, high rates of non-attendance impacts ASHMs ability to continue providing free education. You can cancel your attendance by calling 0431 320 429 or emailing education@ashm.org.au.